Association of Clinical Aspects and Genetic Variants with the Severity of Cisplatin-Induced Ototoxicity in Head and Neck Squamous Cell Carcinoma: A Prospective Cohort Study

SIMPLE SUMMARY: Cisplatin is recognized as the standard agent for head and neck squamous cell carcinoma therapy, despite the relevant risk of permanent hearing damage. The aim of this study was to evaluate the possible associations of the clinicopathological features and inherited genotypes encoding...

Descripción completa

Detalles Bibliográficos
Autores principales: Macedo, Ligia Traldi, Costa, Ericka Francislaine Dias, Carvalho, Bruna Fernandes, Lourenço, Gustavo Jacob, Calonga, Luciane, Castilho, Arthur Menino, Chone, Carlos Takahiro, Lima, Carmen Silvia Passos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046479/
https://www.ncbi.nlm.nih.gov/pubmed/36980643
http://dx.doi.org/10.3390/cancers15061759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046479/
https://www.ncbi.nlm.nih.gov/pubmed/36980643
http://dx.doi.org/10.3390/cancers15061759

Ejemplares similares